No Data
No Data
ATyr Pharma ATYR Phase 1b/2a Data; Summit SMMT Enrollment Completed
12 Health Care Stocks Moving In Friday's Pre-Market Session
Wells Fargo Initiates ATyr Pharma Overweight With $17 Price Target
ATyr Pharma Announces Publication Demonstrating Efficacy Of Efzofitimod In Pulmonary Sarcoidosis In The European Respiratory Journal
Jefferies Initiates ATyr Pharma(ATYR.US) With Buy Rating, Announces Target Price $9
Jefferies analyst Roger Song initiates coverage on $aTyr Pharma(ATYR.US)$ with a buy rating, and sets the target price at $9.According to TipRanks data, the analyst has a success rate of 31.9% and a
Express News | ATyr Pharma Inc : Jefferies Initiates With Buy Rating; Price Target $9